Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development.
Nanosponges (NSs) are a new age branched cyclodextrin (CD) polymeric systems exhibiting tremendous potential in pharmaceutical, agro science, and biomedical applications. Over the past decade, different varieties of NS based on the type of CD and the crosslinker have been developed tailored for specific applications. NS technology has been instrumental in achieving solubilization, stabilization, sustained release, enhancement of activity, permeability enhancement, protein delivery, ocular delivery, stimuli sensitive drug release, enhancement of bioavailability, etc. There is a major explosion of research in the area of NS-aided cancer therapeutics. A wide of anticancer molecules both from a pharmacological and physicochemical perspective have been developed as NS formulations by several groups including ours. Our objective in this review is to capture a systematic and comprehensive snapshot of the state-of-the-art of NS-aided cancer therapeutics reported so far. This review will provide an ideal platform for both the formulation scientists working on new polymeric/drug development and cancer biologists/scientists to understand the current nanotechnologies in CD-based NS-aided cancer therapeutics. The scope of the review is limited to small molecules and CD-based NS. The review covers in detail the problems associated with anticancer small molecules, and the solution provided by CD-based NS specifically for camptothecin, curcumin, paclitaxel, tamoxifen, resveratrol, quercetin, oxygen-NS, temozolomide, doxorubicin, and 5-Fluorouracil. WIREs Nanomed Nanobiotechnol 2016, 8:579-601. doi: 10.1002/wnan.1384 For further resources related to this article, please visit the WIREs website.